☰

Hanwen Zhang - Publications

Affiliations: 
Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dunphy MP, Pressl C, Pillarsetty N, Grkovski M, Modi S, Jhaveri K, Norton L, Beattie BJ, Zanzonico PB, Zatorska D, Taldone T, Ochiana SO, Uddin MM, Burnazi EM, Lyashchenko SK, ... ... Zhang H, et al. First-in-Human Trial of Epichaperome-Targeted Positron Emission Tomography in Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32366671 DOI: 10.1158/1078-0432.Ccr-19-3704  0.388
2020 Zhang H, Maeda M, Shindo M, Ko M, Mane M, Grommes C, Weber W, Blasberg R. Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives. Molecular Imaging and Biology. PMID 32239371 DOI: 10.1007/S11307-020-01480-1  0.349
2018 Zhang H, Kanduluru AK, Desai P, Ahad A, Carlin SD, Tandon N, Weber W, Low PS. Synthesis and evaluation of a novelCu/Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts. Bioconjugate Chemistry. PMID 29466853 DOI: 10.1021/Acs.Bioconjchem.8B00063  0.433
2018 Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J, Omuro AM, Hsieh JJ, Mellinghoff IK, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Gerecitano JF, Kelsen DP, et al. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R )-4-Fluoroglutamine. Radiology. 162610. PMID 29388903 DOI: 10.1148/Radiol.2017162610  0.384
2018 Li JW, Zhang H, Carlin SD, Raj N, Klimstra DS, Libutti SK, Weber WA, Reidy-Lagunes D, Untch BR. Abstract 3735: Somatostatin receptor-based imaging and treatment of murine pancreatic neuroendocrine tumors induced by MEN1-loss Cancer Research. 78: 3735-3735. DOI: 10.1158/1538-7445.Am2018-3735  0.413
2017 Pandit-Taskar N, Zanzonico PB, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko SK, Burnazi E, Zhang H, Lewis JS, Blasberg R, Larson SM, Weber WA, Modak S. Biodistribution and dosimetry of (18)F-Meta Fluorobenzyl Guanidine (MFBG): A first-in-human PET-CT imaging study of patients with neuroendocrine malignancies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28705916 DOI: 10.2967/Jnumed.117.193169  0.376
2017 Kim K, Zhang H, LaRosa S, Jebiwott S, Desai P, Kimm SY, Scherz AJ, O'Donoghue JA, Weber WA, Coleman J. Bombesin Antagonist Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28108545 DOI: 10.1158/1078-0432.Ccr-16-2745  0.383
2016 Taunk NK, Zhang H, Carlin S, Weber W. Monitoring Prostate Cancer Treatment Response to Radiation Therapy and Androgen Deprivation With Novel Radiolabeled and Dual-Labeled Gastrin-Releasing Peptide Receptor (GRPr) Antagonists. International Journal of Radiation Oncology, Biology, Physics. 96: E579-E580. PMID 27675066 DOI: 10.1016/J.Ijrobp.2016.06.2079  0.332
2016 Zhang H, Desai P, Koike Y, Houghton J, Carlin SD, Tandon N, Touijer K, Weber WA. Dual modality imaging of prostate cancer with a fluorescent and radiogallium-labeled GRP receptor antagonist. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27516447 DOI: 10.2967/Jnumed.116.176099  0.376
2016 Demoin DW, Shindo M, Zhang H, Edwards KJ, Serganova I, Pillarsetty NV, Lewis JS, Blasberg RG. Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas. Nuclear Medicine and Biology. 43: 606-611. PMID 27485481 DOI: 10.1016/J.Nucmedbio.2016.05.005  0.343
2016 Lee JT, Zhang H, Moroz MA, Likar Y, Shenker L, Sumzin N, Lobo J, Zurita J, Collins J, van Dam RM, Ponomarev V. Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27393689 DOI: 10.1007/S11307-016-0981-6  0.319
2015 Moroz MA, Zhang H, Lee J, Moroz E, Zurita J, Shenker L, Serganova I, Blasberg R, Ponomarev V. Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1055-60. PMID 26025962 DOI: 10.2967/Jnumed.115.159855  0.306
2015 Lohrmann C, Zhang H, Thorek DL, Desai P, Zanzonico PB, O'Donoghue J, Irwin CP, Reiner T, Grimm J, Weber WA. Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 805-11. PMID 25840974 DOI: 10.2967/Jnumed.114.149054  0.533
2015 Venneti S, Dunphy MP, Zhang H, Pitter KL, Zanzonico P, Campos C, Carlin SD, La Rocca G, Lyashchenko S, Ploessl K, Rohle D, Omuro AM, Cross JR, Brennan CW, Weber WA, et al. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Science Translational Medicine. 7: 274ra17. PMID 25673762 DOI: 10.1126/Scitranslmed.Aaa1009  0.384
2015 Dunphy M, Harding JJ, Lewis JS, Mellinghoff IK, Omuro AMP, Hsieh J, Zhang H, Zanzonico P, Venneti S, Carlin S, Younes A, Gerecitano JF, Lyashchenko SK, Harris L, Lashley A, et al. Phenotypic correlation of tumor uptake of exogenous glutamine radiotracer versus tumor mutational status. Journal of Clinical Oncology. 33: 11014-11014. DOI: 10.1200/Jco.2015.33.15_Suppl.11014  0.361
2014 Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2182-91. PMID 24573553 DOI: 10.1158/1078-0432.Ccr-13-1153  0.361
2014 Carlin S, Zhang H, Reese M, Ramos NN, Chen Q, Ricketts SA. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 515-21. PMID 24491409 DOI: 10.2967/Jnumed.113.126615  0.385
2014 Zhang H, Huang R, Pillarsetty N, Thorek DL, Vaidyanathan G, Serganova I, Blasberg RG, Lewis JS. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter. European Journal of Nuclear Medicine and Molecular Imaging. 41: 322-32. PMID 24173571 DOI: 10.1007/S00259-013-2558-9  0.377
2014 Venneti S, Dunphy M, Zhang H, Pitter K, Campos C, Carlin S, Lyashchenko S, Ploessl C, Rohle D, Omuro A, Cross J, Brennan C, Weber W, Holland E, Mellinghoff I, et al. TM-15 * GLUTAMINE BASED PET IMAGING FACILITATES ENHANCED METABOLIC DETECTION OF GLIOMAS IN VIVO Neuro-Oncology. 16: v216-v216. DOI: 10.1093/Neuonc/Nou278.14  0.372
2012 Zhang H, Abiraj K, Thorek DL, Waser B, Smith-Jones PM, Honer M, Reubi JC, Maecke HR. Evolution of bombesin conjugates for targeted PET imaging of tumors. Plos One. 7: e44046. PMID 23024746 DOI: 10.1371/Journal.Pone.0044046  0.392
2011 Wild D, Frischknecht M, Zhang H, Morgenstern A, Bruchertseifer F, Boisclair J, Provencher-Bolliger A, Reubi JC, Maecke HR. Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN). Cancer Research. 71: 1009-18. PMID 21245097 DOI: 10.1158/0008-5472.Can-10-1186  0.332
2011 Zhang H, Moroz MA, Serganova I, Ku T, Huang R, Vider J, Maecke HR, Larson SM, Blasberg R, Smith-Jones PM. Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOC. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 123-31. PMID 21149478 DOI: 10.2967/Jnumed.110.079004  0.315
2009 Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. Jacc. Cardiovascular Imaging. 2: 1213-22. PMID 19833312 DOI: 10.1016/J.Jcmg.2009.04.016  0.342
2008 Ginj M, Zhang H, Eisenwiener KP, Wild D, Schulz S, Rink H, Cescato R, Reubi JC, Maecke HR. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2019-27. PMID 18381940 DOI: 10.1158/1078-0432.Ccr-07-1687  0.389
2007 Gotthardt M, van Eerd-Vismale J, Oyen WJ, de Jong M, Zhang H, Rolleman E, Maecke HR, Béhé M, Boerman O. Indication for different mechanisms of kidney uptake of radiolabeled peptides. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 596-601. PMID 17401097 DOI: 10.2967/Jnumed.106.036020  0.304
2007 Zhang H, Schuhmacher J, Waser B, Wild D, Eisenhut M, Reubi JC, Maecke HR. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. European Journal of Nuclear Medicine and Molecular Imaging. 34: 1198-208. PMID 17262215 DOI: 10.1007/S00259-006-0347-4  0.363
2007 Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? European Journal of Nuclear Medicine and Molecular Imaging. 34: 982-993. PMID 17225119 DOI: 10.1007/S00259-006-0317-X  0.343
2006 Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X, Erchegyi J, Rivier J, Mäcke HR, Reubi JC. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proceedings of the National Academy of Sciences of the United States of America. 103: 16436-41. PMID 17056720 DOI: 10.1073/Pnas.0607761103  0.388
2005 Schuhmacher J, Zhang H, Doll J, Mäcke HR, Matys R, Hauser H, Henze M, Haberkorn U, Eisenhut M. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 691-9. PMID 15809493  0.322
2004 Zhang H, Chen J, Waldherr C, Hinni K, Waser B, Reubi JC, Maecke HR. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors. Cancer Research. 64: 6707-15. PMID 15374988 DOI: 10.1158/0008-5472.Can-03-3845  0.394
Show low-probability matches.